bought at 58, page-141

Sydney - Thursday - February 19: (RWE Aust Business News) -
Progen Pharmaceuticals (ASX:PGL) reports a cash balance of $72.9m at
December 31, compared with $76.7m at June 30.
The loss for the six months ended 31 December 2008 was
$1,726,000 compared with a loss of $14,393,000 in the previous
corresponding period, which included the financial impact of the
accrual of $4,000,000 in milestone payments in relation to the
termination of the Agreement for Strategic Alliance with Medigen
Biotechnology Corporation.